Crosstalk between metabolic and neuropsychiatric disorders
about
Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative DiseasesA constraint-based modelling approach to metabolic dysfunction in Parkinson's diseaseObesity and psychotic disorders: uncovering common mechanisms through metabolomicsEmerging from the bottleneck: benefits of the comparative approach to modern neuroscienceDiabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disordersAdvancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.Diabetes mellitus and disturbances in brain connectivity: a bidirectional relationship?Moieties in antidiabetic drugs as a target of insulin receptors in association with common neurological disorders.Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance.Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.Molecular and cellular regulation of hypothalamic melanocortin neurons controlling food intake and energy metabolism.Are medical comorbid conditions of bipolar disorder due to immune dysfunction?Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways.Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice.Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression.
P2860
Q26772733-F714E4D1-2A30-49AA-9263-E10FE2C2ADEDQ26778643-0B78F68A-BABC-42A0-AB0A-BDA605181C69Q27011617-B26414AD-68E1-4AC8-B5CD-90402FA7996AQ28083884-E7828D9A-AB80-47DC-8C57-9120BC81C865Q28683010-36779F25-26DC-488A-A3BF-EC46D1EBCA94Q30713152-428D25C1-76EA-4F76-8261-CD5168545B45Q30801268-D5427AB3-9B23-4C24-87CD-F2BE9202DE5EQ30833828-7693AE0E-5372-4490-AA67-B3E61DA32D8FQ36742174-D0AA79F2-6669-4EE8-874D-B611CD21882BQ37102441-90E21797-B3B4-4048-B031-87CD6E999BD5Q37200180-70F278E8-1135-48E0-98D8-69280D416519Q38204626-4859C988-4278-416F-AAC7-5E6B3FBDD68BQ38378743-B5727BEF-DC24-48DA-8D3A-E65BF6998C34Q44273064-19D2D430-A194-46A3-8B22-FB51E9D0EFADQ48339072-3A88084D-2DB7-4330-AF74-2B55603E1777Q55266121-4F95851B-C5CF-4C96-ACBC-86A55877506B
P2860
Crosstalk between metabolic and neuropsychiatric disorders
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Crosstalk between metabolic and neuropsychiatric disorders
@ast
Crosstalk between metabolic and neuropsychiatric disorders
@en
type
label
Crosstalk between metabolic and neuropsychiatric disorders
@ast
Crosstalk between metabolic and neuropsychiatric disorders
@en
prefLabel
Crosstalk between metabolic and neuropsychiatric disorders
@ast
Crosstalk between metabolic and neuropsychiatric disorders
@en
P2860
P356
P1476
Crosstalk between metabolic and neuropsychiatric disorders
@en
P2093
Danielle S Cha
Roger S McIntyre
P2860
P356
10.3410/B4-14
P577
2012-07-02T00:00:00Z